[ad_1]
• The most effective-selling real-time CGM within the world1 is now extra highly effective and simpler to make use of with a small, all-in-one wearable and utterly redesigned cell app
• New system has the quickest sensor warmup in the marketplace,* with no fingersticks† or scanning required
• Dexcom G7 builds on the trusted efficiency of Dexcom CGM, which is clinically confirmed to decrease A1C, scale back hyper- and hypoglycemia, and improve time in range2,3
Dexcom G7 presents a greater approach to assist customers acquire better management of their diabetes, in order that they’ll handle it extra confidently every day. Its low-profile, all-in-one wearable warms up quicker than some other CGM in the marketplace,* sending real-time glucose readings robotically to a appropriate good system‡ or receiver, no fingersticks required.† Dexcom G7 additionally presents a collection of customizable alerts that may warn of excessive or low glucose ranges and assist customers spend extra time in vary.§,2 Trade-leading distant monitoring and reporting capabilities additionally enable customers to remain linked with their family members and care groups anytime, anyplace.||
“At this time marks an unbelievable milestone for our firm and for individuals with diabetes in Europe,” stated Kevin Sayer, chairman, president and CEO of Dexcom. “This all-new platform presents an extremely highly effective CGM that’s easy to make use of, offering our customers with insightful glucose knowledge on one display that helps them spend much less time managing diabetes and extra time doing the issues they love. Dexcom G7 takes every little thing individuals love about G6 and makes it even higher.”
New options with Dexcom G7:
• 60 % smaller, all-in-one, discreet¶ wearable, developed in partnership with Verily
• 30-minute sensor heat up, quickest of any CGM in the marketplace*
• 12-hour grace interval to switch completed sensors for a extra seamless transition between periods
• Redesigned and simplified cell app with Dexcom Readability integration#,**
• Improved alert settings for enhanced discretion
• Redesigned elective receiver that’s smaller, with a extra vibrant, simpler to learn show
• Direct to Apple Watch (anticipated future software program launch)
Dexcom G6 options included with Dexcom G7:
• No fingersticks†, scanning or calibration
• Actual-time glucose readings despatched robotically to a appropriate show system‡
• Indicated for put on on the again of the higher arm and stomach for ages 2 years and older or the higher buttocks for ages 2-17 years previous
• Integration with the world’s largest linked CGM ecosystem
• Distant monitoring, enabling customers to share glucose knowledge with as much as 10 followers||
• Confirmed Dexcom accuracy and performance4
Dexcom can be working intently with its insulin pump companions to combine Dexcom G7 into present and future automated insulin supply programs as rapidly as doable.
“Over the previous 20 years, Dexcom has been one of many leaders and pioneers in advancing real-time CGM know-how,” stated Professor Partha S. Kar, OBE, nationwide specialty advisor, Diabetes at NHS England and advisor endocrinologist at Portsmouth Hospitals NHS Belief. “With enhanced options and added simplicity, Dexcom G7 will hopefully make diabetes administration simpler for each sufferers and their healthcare suppliers, one thing that’s particularly vital as we see an increasing number of proof of the advantages of CGM in broader populations of these dwelling with diabetes.”
Dexcom expects to provoke a launch of Dexcom G7 in Europe within the subsequent a number of weeks. The corporate additionally plans to introduce an up to date CGM algorithm in 2022, driving the subsequent step ahead in CGM sensor efficiency.
Dexcom submitted a complete 510(ok) pre-market notification to the U.S. Meals and Drug Administration for regulatory assessment of the Dexcom G7 CGM System in accordance with the iCGM Particular Controls in This autumn 2021.††
About DexCom, Inc.
Cautionary Assertion Concerning Ahead-Wanting Statements
This press launch incorporates forward-looking statements that aren’t purely historic concerning Dexcom’s or its administration’s intentions, beliefs, expectations and methods for the longer term, together with statements with respect to timing of the G7 launch in Europe, updates to its CGM algorithm and impacts to diabetes administration. All forward-looking statements and the explanation why outcomes may differ included on this press launch are made as of the date of this launch, primarily based on data at the moment obtainable to Dexcom, take care of future occasions, are topic to numerous dangers and uncertainties, together with dangers and uncertainties regarding our improvement, preparation, and potential future submission of a 510(ok) utility for G7 to the US FDA and the potential timing or outcomes of regulatory assessment of such an utility, and precise outcomes might differ materially from these anticipated in these forward-looking statements. The dangers and uncertainties which will trigger precise outcomes to vary materially from Dexcom’s present expectations are extra absolutely described in Dexcom’s Quarterly Report on Type 10-Q for the interval ended September 30, 2021, as filed with the Securities and Change Fee on October 28, 2021. Besides as required by legislation, Dexcom assumes no obligation to replace any such forward-looking assertion after the date of this report or to adapt these forward-looking statements to precise outcomes.
*Dexcom G7 can full warmup inside half-hour, whereas different CGM manufacturers require as much as an hour or longer.
†In case your glucose alerts and readings from Dexcom G7 don’t match signs or expectations, use a blood glucose meter to make diabetes remedy selections.
§Outcomes obtained with a previous technology Dexcom CGM System.
||Separate Dexcom Comply with app and web connection required. Web connectivity required for knowledge sharing. Customers ought to all the time affirm readings on the Dexcom G7 app or receiver earlier than making remedy selections.
¶In comparison with a previous technology Dexcom CGM System.
#Healthcare suppliers can register for Dexcom Readability at readability.dexcom.com/skilled/ registration.
**An web connection is required for sufferers to ship their glucose knowledge to Dexcom Readability through a appropriate good system: dexcom.com/compatibility. Healthcare suppliers will solely have the ability to view a affected person’s glucose knowledge if the affected person elects to share it with them by means of Dexcom Readability.
††Pending 510(ok) clearance — Not obtainable on the market within the U.S.
1 Dexcom, knowledge on file, 2021
2 Beck RW, et al. JAMA. 2017;317(4):371-378.
3 Welsh JB, et al. Diabetes Technol Ther. 2019;21(3):128-132.
4 Dexcom G7 Consumer Information.
Contacts
Media Contact
James McIntosh
619-884-2118
Investor Contact
Sean Christensen
858-203-6657
Supply: DexCom, Inc.
[ad_2]
Source link